United Therapeutics CorporationUTHRNASDAQ
Loading
Cash Flow PerformanceNormalizing
Percentile Rank14
3Y CAGR-2.8%
5Y CAGR-14.2%
Year-over-Year Change
Free cash flow yield
3Y CAGR
-2.8%/yr
vs -19.6%/yr prior
5Y CAGR
-14.2%/yr
Recent acceleration
Acceleration
+16.8pp
Accelerating
Percentile
P14
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
2 yr
Consecutive declineNormalizing
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.82% | -28.8% |
| 2024 | 6.78% | -6.7% |
| 2023 | 7.26% | +38.5% |
| 2022 | 5.25% | +6.6% |
| 2021 | 4.92% | -52.6% |
| 2020 | 10.38% | +237.9% |
| 2019 | -7.52% | -160.0% |
| 2018 | 12.54% | +110.4% |
| 2017 | 5.96% | -37.7% |
| 2016 | 9.56% | - |